-transparent.png){kind=logo}
Five monoclonal antibodies against N-terminal domains of alpha- or beta-tubulin were tested for their ability to interfere with the in vitro formation of microtubules. Although all the antibodies exhibited similar association constants for immobilized tubulin, they differed in their inhibitory effect on microtubule assembly. For the most potent antibody, TU-13, the antibody/tubulin molar ratio of about 1:320 was sufficient for a 50% inhibition. The data indicate that the surface regions of N-terminal domains of tubulin are involved in the formation of microtubules.
Related Publications
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
April 1982,
Biochemical and biophysical research communications,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
September 1986,
International journal of clinical pharmacology, therapy, and toxicology,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
September 1976,
FEBS letters,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
February 1986,
The Journal of biological chemistry,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
September 1987,
Journal of neurochemistry,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
May 1981,
Canadian journal of biochemistry,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
November 1981,
Biochimica et biophysica acta,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
October 1985,
The Journal of biological chemistry,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
January 1977,
Acta biochimica et biophysica; Academiae Scientiarum Hungaricae,
P Dráber, and
W Vater, and
K J Böhm, and
E Kuklova, and
E Unger
November 1983,
Molecular pharmacology,
